We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ALGBE market cap is 22.67M. The company's latest EPS is EUR -0.3231 and P/E is -3.87.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 3.28M | 3.13M | 1.8M | 7.34M | 5M |
| Operating Income | -13.06M | -12.45M | -11.92M | -7.06M | -6.74M |
| Net Income | -11.15M | -11.77M | -11.99M | -8.66M | -5.86M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 25.8M | 31.79M | 21.58M | 18.25M | 9.65M |
| Total Liabilities | 21.67M | 13.12M | 13.93M | 7.85M | 15.39M |
| Total Equity | 4.13M | 18.66M | 7.65M | 10.41M | -5.74M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -10.68M | -11.88M | -10.15M | -7.9M | N/A |
| Investing | -607k | -2.49M | -1.93M | 887k | N/A |
| Financing | 9.48M | 21.14M | -135k | 9.91M | N/A |
| Market Cap | 22.67M |
| Price to Earnings Ratio | -3.87 |
| Price to Sales Ratio | 4.53 |
| Price to Cash Ratio | 4.83 |
| Price to Book Ratio | -3.95 |
| Dividend Yield | - |
| Shares Outstanding | 18.14M |
| Average Volume (1 week) | 18.64k |
| Average Volume (1 Month) | 26.16k |
| 52 Week Change | -34.14% |
| 52 Week High | 2.13 |
| 52 Week Low | 0.432 |
| Spread (Intraday) | 0.01 (0.79%) |
| Company Name | Global Bioenergies |
| Address |
5 rue henri desbrueres evry, essonne 91000 |
| Website | https://www.global-bioenergies.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
